| Bioactivity | Cbl-b-IN-7 (Compound 248) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 6.7 nM and 5.2 nM, respectively[1]. |
| Target | IC50: 5.2 nM (c-Cbl), 6.7 nM (Cbl-b) |
| Name | Cbl-b-IN-7 |
| CAS | 2815221-35-1 |
| Formula | C29H31F4N5O2 |
| Molar Mass | 557.58 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Jun Liang, et al. Lactams as cbl-b inhibitors. Patent WO2022169997A1. |
Cbl-b-IN-7
CAS: 2815221-35-1 F: C29H31F4N5O2 W: 557.58
Cbl-b-IN-7 (Compound 248) is a casitas B-lineage lymphoma-b (Cbl-b) and c-Cbl inhibitor with IC50s of 6.7 nM and 5.2 nM,
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.